CTD Holdings Closes $1.5 Million Private Placement

ALACHUA, FL CTDH, (Marketwired October 18, 2017)  CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that it has closed a private placement of its securities with a group of accredited investors that included several directors of the Company and members of management. Investors in the private placement purchased 15,000 Units at a price per Unit of $100.00. Each Unit consisted of one share of
http://bit.ly/2ys4Cs4